CSF3 and cancer: Given its key role in host defense, the most effective strategies to neutralize the pro-tumorigenic effects of endogenous G-CSF in the setting of adjunctive anti-cancer therapy are likely to involve pharmacologic targeting of the CXCR1 and CXCR2 chemokine receptors.